全球器官晶片市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

全球器官晶片市場需求預計將從 2022 年的 88.45 萬美元達到 2030 年近 1,049.83 萬美元的市場規模，2023-2030 年研究期間CAGR為 36.24%。

器官晶片（OOC）是一種能夠模仿人體器官結構和功能的微流控細胞培養裝置。它的目的是複製特定器官的生理和機械方面，以提供比傳統細胞培養方法更準確和動態的人類生物學表徵。每個設備都旨在模擬特定器官或組織的微環境和細胞相互作用。

市場動態：

由於其在生物醫學研究和藥物開發方面的變革潛力，器官晶片市場正在迅速擴大。該技術透過提供更多與人類相關的器官和組織表示來解決傳統模型的局限性。它為動物測試提供了一種人道的替代方案，符合日益增加的道德問題和監管壓力。 OOC 平台準確模仿人類生物學的能力對藥物開發具有深遠的影響，增強了對藥物功效和安全性的預測。此外，這些模型透過允許研究個體對治療的反應來支持個人化醫療的進步。該市場進一步受到政府、研究機構和製藥公司投資的推動，促進了合作和技術進步。微加工技術的不斷改進有助於提高 OOC 系統的可擴展性和複雜性。隨著慢性病的增加，監管機構對 OOC 模型的驗證強調了它們徹底改變醫療保健和研究實踐的潛力。隨著合作關係的蓬勃發展和接受度的提高，器官晶片技術有望在重塑生物醫學研究和治療開發方面發揮關鍵作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球晶片器官市場的各個細分市場進行了包容性評估。晶片上器官產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的晶片器官市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。器官晶片市場的主要參與者包括 Emulate, Inc.、MIMETAS BV、Valo Health、Nortis, Inc.、AxoSim、BICO - THE BIO CONVERGENCE COMPANY、CN Bio Innovations Ltd、SynVivo, Inc.、The Charles Stark Draper實驗室有限公司，AlveoliX AG。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：器官晶片 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品和服務分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球晶片器官市場分析：按產品和服務分類

• 按產品和服務分類的概述
• 歷史和預測數據
• 按產品和服務分析
• 產品
• 儀器
• 器官晶片設備（晶片肝臟、晶片肺、晶片腸、晶片腎臟、晶片心臟等）
• 服務

第 6 章：全球晶片器官市場分析：依應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 藥物發現
• 毒理學研究
• 其他

第 7 章：全球晶片器官市場分析：依最終用途分類

• 按最終用途分類的概述
• 歷史和預測數據
• 按最終用途分析
• 學術及研究機構
• 製藥與生物技術公司
• 其他

第 8 章：全球晶片器官市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：晶片器官公司的競爭格局

• 器官晶片市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• Emulate Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• MIMETAS BV
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Valo Health
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Nortis Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• AxoSim
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• BICO - THE BIO CONVERGENCE COMPANY
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• CN Bio Innovations Ltd
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• SynVivo Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• The Charles Stark Draper Laboratory Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• AlveoliX AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Organ On A Chip Market is presumed to reach the market size of nearly USD 1049.83 MN by 2030 from USD 88.45 MN in 2022 with a CAGR of 36.24% under the study period 2023 - 2030.

An Organ-on-a-Chip (OOC) is a microfluidic cell culture device that is able to mimic the structure and function of human organs. It aims to replicate the physiological and mechanical aspects of specific organs to provide a more accurate and dynamic representation of human biology compared to traditional cell culture methods. Each device is designed to simulate the microenvironment and cellular interactions of a particular organ or tissue.

MARKET DYNAMICS:

The organ-on-a-chip market is expanding rapidly due to its transformative potential in biomedical research and drug development. This technology addresses the limitations of traditional models by providing more human-relevant representations of organs and tissues. It offers a humane alternative to animal testing, aligning with increasing ethical concerns and regulatory pressures. The ability of OOC platforms to mimic human biology accurately has profound implications for drug development, enhancing predictions of drug efficacy and safety. Moreover, these models support the advancement of personalized medicine by allowing the study of individual responses to treatments. The market is further driven by investments from governments, research institutions, and pharmaceutical companies, fostering collaborations and technological advancements. Ongoing improvements in microfabrication technology contribute to the scalability and complexity of OOC systems. With rising chronic diseases, the validation of OOC models by regulatory authorities underscores their potential to revolutionize healthcare and research practices. As partnerships flourish and acceptance grows, Organ-on-a-Chip technology is poised to play a pivotal role in reshaping biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organ on a chip. The growth and trends of organ on a chip industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the organ on a chip market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

• Products
• Instruments
• Organ-On-A-Chip Devices (Liver-On-A-Chip, Lung-On-A-Chip, Intestine-On-A-Chip, Kidney-On-A-Chip, Heart-On-A-Chip, Others)
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End-Use

• Academic And Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Organ On A Chip market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organ On A Chip market include Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc., AlveoliX AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORGAN ON A CHIP - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Service
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY PRODUCT & SERVICE

• 5.1 Overview by Product & Service
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product & Service
• 5.4 Products Historic and Forecast Sales by Regions
• 5.5 Instruments Historic and Forecast Sales by Regions
• 5.6 Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Historic and Forecast Sales by Regions
• 5.7 Services Historic and Forecast Sales by Regions

6 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Drug Discovery Historic and Forecast Sales by Regions
• 6.5 Toxicology Research Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Academic and Research Institutes Historic and Forecast Sales by Regions
• 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGAN ON A CHIP COMPANIES

• 9.1. Organ On A Chip Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ORGAN ON A CHIP INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Emulate Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. MIMETAS B.V.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Valo Health
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Nortis Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AxoSim
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. BICO - THE BIO CONVERGENCE COMPANY
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. CN Bio Innovations Ltd
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. SynVivo Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. The Charles Stark Draper Laboratory Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. AlveoliX AG
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product & Service (USD MN)
• Products Market Sales by Geography (USD MN)
• Instruments Market Sales by Geography (USD MN)
• Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
• Services Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Drug Discovery Market Sales by Geography (USD MN)
• Toxicology Research Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Academic and Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Organ On A Chip Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Organ On A Chip Report
• Market Research Process
• Market Research Methodology
• Global Organ On A Chip Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product & Service
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product & Service (USD MN)
• Products Market Sales by Geography (USD MN)
• Instruments Market Sales by Geography (USD MN)
• Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
• Services Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Drug Discovery Market Sales by Geography (USD MN)
• Toxicology Research Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Academic and Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.